The resulting
particles are known as Gram-positive enhancer matrix
(GEMs). The procedure applies the antigen–PA fusion proteins
produced and purified from (recombinant) Escherichia
coli or L. lactis, which subsequently are mixed with GEM
particles. GEMparticles reveal higher binding ability of fused
proteins containing PA domain than live LAB cells